Convatec Group (FRA:2CV) PE Ratio: 33.78 (As of Jun. 30, 2026) — 28% Below Median


FRA:2CV Convatec Group PLC FRA:2CV
77 GF Score
Price €2.50
GF Value €2.96
! 4 Warning Signs
View Full Analysis

What is Convatec Group PE Ratio?

Convatec Group FRA:2CV +1.63% 77 PE Ratio is 33.78 as of Jun. 30, 2026, which is 28% below its 10-year median of 46.91. GuruFocus rates FRA:2CV with a GF Score™ of 77/100 and a GF Value™ of €2.96. The stock has 4 warning signs investors should review.

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-06-30), Convatec Group's share price is €2.50. Convatec Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.07. Therefore, Convatec Group's PE Ratio for today is 33.78.

Good Sign:

Convatec Group PLC stock PE Ratio (=33.06) is close to 1-year low of 30.43.

During the past 13 years, Convatec Group's highest PE Ratio was 540.50. The lowest was 13.63. And the median was 46.91.

Convatec Group's EPS (Diluted) for the six months ended in Dec. 2025 was €0.03. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.07.

As of today (2026-06-30), Convatec Group's share price is €2.50. Convatec Group's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was €0.15. Therefore, Convatec Group's PE Ratio without NRI ratio for today is 16.56.

During the past 13 years, Convatec Group's highest PE Ratio without NRI was 37.16. The lowest was 9.41. And the median was 21.50.

Convatec Group's EPS without NRI for the six months ended in Dec. 2025 was €0.08. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was €0.15.

During the past 12 months, Convatec Group's average EPS without NRI Growth Rate was 9.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 8.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 7.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was 3.00% per year.

During the past 13 years, Convatec Group's highest 3-Year average EPS without NRI Growth Rate was 175.00% per year. The lowest was -9.20% per year. And the median was 6.00% per year.

Convatec Group's EPS (Basic) for the six months ended in Dec. 2025 was €0.03. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.07.

Back to Basics: PE Ratio


Convatec Group  (FRA:2CV) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Convatec Group PE Ratio Related Terms


Convatec Group PE Ratio Historical Data

* Premium members only.

The historical data trend for Convatec Group's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Convatec Group PE Ratio Chart

Convatec Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.90 93.04 48.84 29.89 38.00

Convatec Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.84 At Loss 29.89 At Loss 38.00

FRA:2CV vs ISRG, BDX, MDLN: PE Ratio Comparison

For the Medical Instruments & Supplies subindustry, Convatec Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Convatec Group PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Convatec Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where Convatec Group's PE Ratio falls into.


FRA:2CV
77GF Score
Convatec Group PLC FRA:2CV
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Convatec Group PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Convatec Group's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=2.50/0.074
=33.78

Convatec Group's Share Price of today is €2.50.
For company reported semi-annually, Convatec Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.07.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 33.78 mean?
Convatec Group (FRA:2CV) has a PE Ratio of 33.78 as of Jun. 30, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Convatec Group and its competitors. This is 28% below median its historical median of 46.91. Over the past decade, Convatec Group's PE Ratio has ranged from 13.63 to 540.50.
Is Convatec Group's PE Ratio too high?
Convatec Group's current PE Ratio of 33.78 is 28% below median its 10-year median of 46.91. Over the past 10 years, this metric has ranged from a low of 13.63 to a high of 540.50. Overall, Convatec Group has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Convatec Group's PE Ratio compare to ISRG and BDX?
Convatec Group's PE Ratio of 33.78 can be compared against companies in the Medical Devices & Instruments industry. Historically, Convatec Group's own PE Ratio has ranged from 13.63 to 540.50 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Medical Devices & Instruments company?
A good PE Ratio depends on the Medical Devices & Instruments industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Convatec Group and its competitors. Convatec Group's current PE Ratio is 33.78, which is 28% below median its own 10-year median of 46.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Convatec Group stock overvalued right now?
Convatec Group (FRA:2CV) has a current PE Ratio of 33.78. The stock's GF Value™ is €2.96, compared to a current price of €2.50 — trading 15.5% below its estimated fair value. The current PE Ratio is 33.78, which is 28% below median its 10-year median of 46.91. Convatec Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For Convatec Group (FRA:2CV), the current PE Ratio is 33.78 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Convatec Group (FRA:2CV) Overvalued in 2026?

Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued. The current stock price of €2.50 is trading 15.5% below its estimated GF Value™ of €2.96.

Key valuation signals for FRA:2CV:

  • PE Ratio: 33.78 (28% below median its 10-year median of 46.91)
  • GF Value™: €2.96 vs. price of €2.50 (15.5% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the FRA:2CV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Convatec Group Business Description

Address 20 Eastbourne Terrace, 7th Floor, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score

Get the complete analysis for FRA:2CV

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.50
Price
€2.96
GF Value